MoneyWorks4Me

Cipla informs about press release

04 Sep 2015 Evaluate

Cipla has informed about a Press Release dated September 04, 2015 titled ‘Cipla to acquire 100% of generic businesses in US for $550M’.

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1418.20 -13.65 (-0.95%)
19-Aug-2026 14:09 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1893.00
Dr. Reddys Labs. 1169.80
Cipla 1418.20
Lupin 2221.50
Zydus Lifesciences 1107.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: